Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
11.75 EUR | -1.67% | -2.08% | -7.84% |
Mar. 14 | Hyloris Pharmaceuticals SA Provides Earnings Guidance for 2024 | CI |
Mar. 14 | Transcript : Hyloris Pharmaceuticals SA, 2023 Earnings Call, Mar 14, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-7.84% | 356M | |
+26.06% | 659B | |
+26.51% | 557B | |
-4.81% | 359B | |
+16.99% | 322B | |
+9.12% | 297B | |
+6.21% | 215B | |
+5.22% | 210B | |
-6.05% | 200B | |
-8.39% | 149B |
- Stock Market
- Equities
- HYL Stock
- News Hyloris Pharmaceuticals SA
- Hyloris Pharmaceuticals : Acquires Global Rights to Heart Failure Drug